Endoscopic Therapy for Esophageal Achalasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new and existing endoscopic treatments for individuals with esophageal achalasia and other gastrointestinal issues. The researchers aim to identify the best management strategies using less invasive techniques, such as POEM (Percutaneous Oral Endoscopic Myomectomy), which improves esophageal function. This procedure suits those with frequent heartburn, difficulty swallowing due to achalasia, or complications after weight loss surgery. Participants should have a history of these conditions and be considering surgery. As an unphased trial, this study allows participants to contribute to innovative research that could enhance treatment options for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that endoscopic intervention is safe for esophageal achalasia?
Studies have shown that procedures like POEM (Peroral Endoscopic Myotomy) are generally safe for treating achalasia, a condition where the esophagus struggles to move food to the stomach. Research indicates that POEM is not only effective but also well-tolerated by most patients. One study found that patients' symptoms improved significantly after the procedure, with over 86% experiencing success one year later. Another study noted that POEM remains safe even for those who had unsuccessful treatments before. Although POEM might lead to more healthcare visits compared to another surgery type (LHM), its safety and effectiveness are well-documented, making it a promising option for those with esophageal muscle issues.12345
Why are researchers excited about this trial?
Researchers are excited about endoscopic interventions for esophageal achalasia because they offer a less invasive alternative to traditional surgical methods like laparoscopic Heller myotomy. One of the standout features is the Percutaneous Oral Endoscopic Myomectomy (POEM), which uses an endoscope to reach and treat the affected area from within the esophagus, reducing recovery time and potential complications. This method provides a targeted approach that can be performed without large incisions, making it a promising option for patients seeking effective treatment with minimal disruption to their lives.
What evidence suggests that endoscopic intervention is effective for esophageal achalasia?
Studies have shown that endoscopic treatments like per-oral endoscopic myotomy (POEM) effectively treat achalasia, a condition where the esophagus struggles to move food to the stomach. In this trial, participants will receive endoscopic interventions, including POEM. Research indicates that POEM is safe, involves a minimally invasive procedure, and provides excellent long-term results. The procedure uses a flexible tube with a camera and tools to cut the muscles causing the swallowing problem. This method is as effective as traditional surgery but offers a shorter recovery time. Overall, POEM presents a promising option for people with achalasia.678910
Who Is on the Research Team?
Mohamed R Ali, MD
Principal Investigator
U.C. Davis Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 with various upper and lower GI conditions, including Achalasia, Barrett's Esophagus, GERD, and complications from bariatric surgery. Candidates must qualify for gastrointestinal surgeries of benign or malignant nature. Those unable to consent or not meeting the criteria for endoluminal treatments are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive endoluminal therapies such as POEM or endoscopic interventions for gastrointestinal conditions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Endoscopic Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor